These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7443435)

  • 21. Mode of action of probucol in reducing serum cholesterol in mice.
    Tawara K; Tomikawa M; Abiko Y
    Jpn J Pharmacol; 1986 Jan; 40(1):123-33. PubMed ID: 3959347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
    Hirano K; Ikegami C; Tsujii K; Zhang Z; Matsuura F; Nakagawa-Toyama Y; Koseki M; Masuda D; Maruyama T; Shimomura I; Ueda Y; Yamashita S
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2422-7. PubMed ID: 16151015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of (4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol)), probucol, in mice, rats, dogs and monkeys: demonstration of a species-specific phenomenon.
    Molello JA; Gerbig CG; Robinson VB
    Toxicol Appl Pharmacol; 1973 Apr; 24(4):590-3. PubMed ID: 4197359
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of probucol and its new analog on cholesterol and lipoprotein metabolism in rabbit cultured hepatocytes].
    Mambetisaeva ET; Kosenkov EI; Podrez EA; Samuilov IaD; Kosykh VA
    Biokhimiia; 1994 Jan; 59(1):118-25. PubMed ID: 8117833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probucol and liver efficiency during chemically-induced hepatocarcinogenesis.
    el-Demerdash E; el-Denshary Eel-D; el-didi M; Al-Gharabli N; Osman AM
    Anticancer Res; 2002; 22(2A):977-84. PubMed ID: 12014681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N; Singal PK
    Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol.
    Jeon SM; Park YB; Kwon OS; Huh TL; Lee WH; Do KM; Park T; Choi MS
    J Biochem Mol Toxicol; 2005; 19(5):336-46. PubMed ID: 16292755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effect of probucol and insulin on renal damage in diabetic rats fed a high cholesterol diet.
    Yoshida M; Kimura H; Kyuki K; Ito M
    Eur J Pharmacol; 2006 Oct; 548(1-3):174-80. PubMed ID: 16979162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
    El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanism of action of probucol.
    Steinberg D
    Am J Cardiol; 1986 Jun; 57(16):16H-21H. PubMed ID: 3728306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical studies on acemetacin/Experimental tests in animals (author's transl)].
    Dell HD; Doersing M; Fischer W; Jacobi H; Kamp R
    Arzneimittelforschung; 1980; 30(8A):1371-83. PubMed ID: 7191304
    [No Abstract]   [Full Text] [Related]  

  • 33. [Probucol and alpha-tocopherol stimulate the synthesis of bile acids in cultured rabbit hepatocytes].
    Lakeev IuV; Kosykh VA; Kosenkov EI; Tsibul'skiĭ VP; Tikhomirov OIu; Antonov IA; Repin VS
    Biokhimiia; 1993 Mar; 58(3):406-15. PubMed ID: 8485228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effect of probucol and insulin on cataracts of diabetic rats fed a high cholesterol diet.
    Yoshida M; Kimura H; Kyuki K; Ito M
    Eur J Pharmacol; 2005 Apr; 513(1-2):159-68. PubMed ID: 15869753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma levels of probucol in man after single and repeated oral doses (author's transl)].
    Heeg JF; Tachizawa H
    Nouv Presse Med; 1980 Oct; 9(40):2990-4. PubMed ID: 7443437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probucol: pharmacology and clinical application.
    Zimetbaum P; Eder H; Frishman W
    J Clin Pharmacol; 1990 Jan; 30(1):3-9. PubMed ID: 2406299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle processing in the solid state dramatically increases the cell membrane permeation of a cholesterol-lowering drug, probucol.
    Fukami T; Ishii T; Io T; Suzuki N; Suzuki T; Yamamoto K; Xu J; Ramamoorthy A; Tomono K
    Mol Pharm; 2009; 6(3):1029-35. PubMed ID: 19281185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Probucol, HDL and inverse transport of cholesterol].
    Med Clin (Barc); 1989 Oct; 93(13):22-3 p.. PubMed ID: 2695695
    [No Abstract]   [Full Text] [Related]  

  • 39. [Probucol in the treatment of hyperlipidemias].
    Feder D; Langer AL; Alexandrino E; Medeiros S; Lotto M; Valente O
    Arq Bras Cardiol; 1986 Feb; 46(2):77-80. PubMed ID: 3827649
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbits.
    Aburatani H; Matsumoto A; Kodama T; Takaku F; Fukazawa C; Itakura H
    Am J Cardiol; 1988 Jul; 62(3):60B-65B. PubMed ID: 3394655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.